Managing IP Ranks Marshall, Gerstein & Borun as a Top Patent Firm

February 16, 2015

Marshall, Gerstein & Borun LLP has been ranked by Managing IPas one of the world's leading patent firms in 2015. The Firm was ranked nationally for Bio Life Sciences, Patent Prosecution, and Patent Contentious. The results are based on Managing IP's World IP Survey, the industry's oldest detailed analysis of leading intellectual property firms worldwide.

The Firm's Biotechnology Group includes lawyers and patent agents who have broad experience in a variety of biotechnology disciplines, including: DNA, RNA, vaccine, protein, and antibody therapeutics and diagnostics; cell-based and viral therapeutics; drug and gene therapy delivery vehicles; plant biotechnology; industrial technology and research platforms; nanotechnology and interdisciplinary inventions. The Firm's professionals are skilled at providing patent counseling relating to the interface between patents, clinical product development, FDA regulations and regulatory exclusivity.

Marshall, Gerstein & Borun LLP is experienced in traditional, chemical-based pharmaceuticals, formulations, and delivery technologies. The Firm has procured, enforced and/or defended patents for biotech companies relating to a number of billion-dollar biologic or pharmaceutical products and has handled key patents for clients covering more than a dozen different commercially marketed pharmaceutical products and numerous clinical trial candidates.